Wearables have spent years collecting heart-rate data without doing much with it beyond a sleep score and a weekly summary. A new clinical study run by Samsung with Korea's Chung-Ang University Gwangmyeong Hospital changes that. The team showed that the Samsung Galaxy Watch6 can predict a fainting episode up to five minutes before it happens, with 84.6 percent accuracy. The findings have been published in the European Heart Journal, Digital Health.
Editor
Kai T chevron_right
Table of Contents
What the watch actually predicts
The target is vasovagal syncope. It is the most common kind of fainting, triggered when the body overreacts to something like prolonged standing, stress, the sight of blood, or sudden heat. Blood pressure and heart rate drop, the brain loses oxygen briefly, and the person passes out. For most people it is a one-off scare. For people with recurring episodes it is a daily safety risk, especially when driving, climbing stairs, or working alone.
The study ran the Galaxy Watch6 on 132 patients with a history of vasovagal syncope. The watch's photoplethysmography (PPG) sensor read pulse waveforms continuously, and an AI model trained on heart rate variability picked up the pattern shifts that come ahead of an episode. Five minutes is not a lot of time, but it is enough to sit down, get off a flight of stairs, or move away from a busy road.
Why this matters for Malaysian Galaxy Watch users
The research itself was done in Korea. The interesting part is what it signals about where Samsung's wearable team is pushing. The Galaxy Watch line in Malaysia already supports ECG, blood pressure tracking after a calibrated cuff measurement, and sleep apnoea detection. Fainting prediction is a different category: it is predictive rather than reactive, and it relies on signals the watch is already collecting.
Samsung has not said when, or whether, this feature will ship as a software update to existing Galaxy Watch6 units in Malaysia, or whether regulators here would need to clear it the way the ECG and blood pressure features did before going live locally. The MDA in Malaysia and Korea's MFDS apply different timelines for software-as-a-medical-device.
How it stacks up against the alternatives
Clinics use a tilt-table test to diagnose vasovagal syncope, which involves strapping a patient to a table that tilts upright while their vitals are measured. It is accurate but expensive and unpleasant. Holter monitors and event recorders can record an episode after it happens, but they cannot warn anyone before. A continuous wearable that delivers a five-minute warning at 84.6 percent accuracy is a different model: passive monitoring with an actionable heads-up.
The Apple Watch has separately been used in academic studies for atrial fibrillation and falls, and Fitbit's research arm has worked on AFib screening. None has shipped a syncope-prediction feature yet. Samsung is the first to put a peer-reviewed claim on the board.
The takeaway
For Malaysian Galaxy Watch6 owners, this is not a new feature you can switch on tonight. It is a research breakthrough that says the hardware on your wrist already carries enough signal for something useful, and Samsung is willing to publish the work in a cardiology journal rather than just a marketing slide. If you have ever felt that smartwatches are good at counting steps and not much else, this is a quiet shift in what the category can do.